The shot, dubbed mNexspike, is approved for older adults and people whose health conditions put them at higher risk of severe ...

The U.S. Food and Drug Administration has approved Moderna’s next-generation COVID-19 vaccine for everyone aged ...

The FDA approved Novavax’s COVID vaccine Nuvaxovid this month, limiting its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.

The US FDA has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, for use in adults aged 65 and older.